If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHammerson Regulatory News (HMSO)

Share Price Information for Hammerson (HMSO)

Share Price is delayed by 15 minutes
Get Live Data
363.60    3.20 (0.89%)
Bid:
363.60
Ask:
364.40
Spread: 0.80 (0.22%)
Market Cap: £1.93b
HMSO Live PriceLast checked at - London Stock Exchange

Intraday Hammerson Share Chart

Interim Dividend and Enhanced Scrip Alternative

8 Dec 2020 13:15

RNS Number : 9480H
Hammerson PLC
08 December 2020
 

THIS ANNOUNCEMENT (AND THE INFORMATION CONTAINED HEREIN) IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH JURISDICTION.

FOR IMMEDIATE RELEASE

Hammerson plc

Interim 2020 Dividend and Enhanced Scrip Dividend Alternative

8 December 2020

 

Further to the announcement of the Interim 2020 Dividend and the Enhanced Scrip Dividend Alternative on 11 November 2020, the Board of Hammerson plc (the Company) announced that valid elections to participate in the Enhanced Scrip Dividend Alternative were received from Shareholders holding 3,108,216,704 Shares. Accordingly, the number of New Shares to be issued under the Enhanced Scrip Dividend Alternative is 225,830,124

 

Therefore, 189,816,827 New Shares will be admitted to trading on the London Stock Exchange and 36,013,297 New Shares will be admitted to trading on the Johannesburg Stock Exchange, bringing the total number of issued 5 pence ordinary shares in the Company to 4,057,298,174.

 

The New Shares are expected to be issued and admitted to trading on the Main Market of the London Stock Exchange and the Johannesburg Stock Exchange on 18 December 2020. A further announcement will be released to confirm when those New Shares have been issued and admitted to trading on the respective stock exchange.

 

Unless otherwise stated, capitalised terms in this announcement shall have the meanings given to them in the Circular dated 11 November 2020 in connection with the proposed Interim 2020 Dividend and Enhanced Scrip Dividend Alternative which can be found at: https://www.hammerson.com/investors/shareholder-information/general-meeting.

 

Enquiries

Josh Warren, Head of Investor Relations

Tel: +44 20 7887 1053

josh.warren@hammerson.com

 

The announcement above has also been released on the SENS system of the Johannesburg Stock Exchange.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVTPBTTMTJMBLM
Date   Source Headline
29th Mar 20219:30 amRNSHolding(s) in Company
24th Mar 20213:30 pmRNSDirector/PDMR Shareholding
24th Mar 20211:15 pmRNSScrip Reference Price & Scrip Ratios - Replacement
24th Mar 202112:30 pmRNSHolding(s) in Company
23rd Mar 20211:30 pmRNSHolding(s) in Company
23rd Mar 20218:30 amRNSCurrency Conversion & Scrip Reference Share Price
18th Mar 202110:30 amRNSHolding(s) in Company
17th Mar 20211:45 pmRNSDirector/PDMR Shareholding
17th Mar 202110:15 amRNSHolding(s) in Company
16th Mar 20211:15 pmRNSHolding(s) in Company
15th Mar 202111:15 amRNSHolding(s) in Company
12th Mar 20217:01 amRNSDividend Declaration
12th Mar 20217:00 amRNSBoard Changes
12th Mar 20217:00 amRNSFinal Results
11th Mar 20213:30 pmRNSHolding(s) in Company
11th Mar 20219:30 amRNSHolding(s) in Company
10th Mar 202110:15 amRNSHolding(s) in Company
2nd Mar 202110:15 amRNSHolding(s) in Company
1st Mar 202110:15 amRNSHolding(s) in Company
26th Feb 202110:15 amRNSHolding(s) in Company
23rd Feb 20219:30 amRNSHolding(s) in Company
22nd Feb 202111:00 amRNSHolding(s) in Company
19th Feb 202111:00 amRNSHolding(s) in Company
16th Feb 20219:30 amRNSHolding(s) in Company
15th Feb 202111:30 amRNSNotification of 2020 Full Year Results
29th Jan 20213:30 pmRNSDirector/PDMR Shareholding
19th Jan 20217:00 amRNSOperational and Rent Collection Update
15th Jan 20217:00 amRNSBoard Change
12th Jan 20213:30 pmRNSHolding(s) in Company
8th Jan 202110:30 amRNSHome Member State
8th Jan 20219:30 amRNSHolding(s) in Company
6th Jan 20213:45 pmRNSHolding(s) in Company
24th Dec 20208:30 amRNSNotification of Transactions of Directors /PDMRs
23rd Dec 20208:01 amRNSAdmission to the official list of Euronext Dublin
22nd Dec 20209:30 amRNSHolding(s) in Company
21st Dec 20207:00 amRNSAppointment of new Non-Executive Director
18th Dec 20209:00 amRNSTotal Voting Rights
18th Dec 20207:00 amRNSIntention to seek admission to Euronext Dublin
16th Dec 202012:00 pmRNSInterim 2020 Dividend/Enhanced Script Correction
14th Dec 202010:30 amRNSHolding(s) in Company
8th Dec 20201:15 pmRNSInterim Dividend and Enhanced Scrip Alternative
4th Dec 202012:15 pmRNSResults of the General Meeting
2nd Dec 20209:30 amRNSHolding(s) in Company
30th Nov 20209:30 amRNSBlock listing Interim Review
25th Nov 202010:30 amRNSHolding(s) in Company
19th Nov 20209:00 amRNSCash Fractions for the Enhanced Scrip Dividend
18th Nov 20207:20 amRNSScrip Ratio Announcement
17th Nov 20208:00 amRNSCurrency Conversion & Scrip Reference Share Price
16th Nov 202010:00 amRNSHolding(s) in Company
11th Nov 20207:00 amRNSInterim Dividend and Enhanced Scrip Alternative

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.